The sequential production of neurons and astrocytes from neuroepithelial precursors is a fundamental feature of central nervous system development. We report that LIM-homeodomain (LIM-HD) transcription factor Lhx2 regulates this transition in the developing hippocampus. Disrupting Lhx2 function in the embryonic hippocampus by in utero electroporation and in organotypic slice culture caused the premature production of astrocytes at stages when neurons are normally generated. Lhx2 function is therefore necessary to suppress astrogliogenesis during the neurogenic period. Furthermore, Lhx2 overexpression was sufficient to suppress astrogliogenesis and prolong the neurogenic period. We provide evidence that Lhx2 overexpression can counteract the instructive astrogliogenic effect of Notch activation. Lhx2 overexpression was also able to override and suppress the activation of the GFAP promoter by Nfia, a Notch-regulated transcription factor that is required for gliogenesis. Thus, Lhx2 appears to act as a "brake" on Notch/Nfia-mediated astrogliogenesis. This critical role for Lhx2 is spatially restricted to the hippocampus, because loss of Lhx2 function in the neocortex did not result in premature astrogliogenesis at the expense of neurogenesis. Our results therefore place Lhx2 as a central regulator of the neuron-glia cell fate decision in the hippocampus and reveal a striking regional specificity of this fundamental function within the dorsal telencephalon.
The sequential production of neurons and astrocytes from neuroepithelial precursors is a fundamental feature of central nervous system development. We report that LIM-homeodomain (LIM-HD) transcription factor Lhx2 regulates this transition in the developing hippocampus. Disrupting Lhx2 function in the embryonic hippocampus by in utero electroporation and in organotypic slice culture caused the premature production of astrocytes at stages when neurons are normally generated. Lhx2 function is therefore necessary to suppress astrogliogenesis during the neurogenic period. Furthermore, Lhx2 overexpression was sufficient to suppress astrogliogenesis and prolong the neurogenic period. We provide evidence that Lhx2 overexpression can counteract the instructive astrogliogenic effect of Notch activation. Lhx2 overexpression was also able to override and suppress the activation of the GFAP promoter by Nfia, a Notch-regulated transcription factor that is required for gliogenesis. Thus, Lhx2 appears to act as a "brake" on Notch/Nfia-mediated astrogliogenesis. This critical role for Lhx2 is spatially restricted to the hippocampus, because loss of Lhx2 function in the neocortex did not result in premature astrogliogenesis at the expense of neurogenesis. Our results therefore place Lhx2 as a central regulator of the neuron-glia cell fate decision in the hippocampus and reveal a striking regional specificity of this fundamental function within the dorsal telencephalon. D uring the development of the vertebrate CNS, progenitors in the early proliferative neuroepithelium are specified both in terms of their regional identity and in terms of the cell types they will generate. In the telencephalon, LIM-homeodomain (LIM-HD) transcription factor Lhx2 acts as a "selector gene" for cerebral cortical fate. In the absence of Lhx2, the cortical primordium (hippocampus and neocortex) is lost at the expense of alternative noncortical (hem and antihem) fates (1) (2) (3) . This is an early role for Lhx2, the critical period for which ends at embryonic gestation day (E) 10.5. After this age, loss of Lhx2 does not cause loss of the cortical primordium (3) . However, Lhx2 continues to be expressed in the telencephalic ventricular zone after E10.5 and remains strongly expressed in the hippocampal ventricular zone at midlate gestation stages when hippocampal neurogenesis is underway (4) . We tested the hypothesis that Lhx2 may have additional functions in hippocampal progenitors during neurogenesis.
Progenitors throughout the CNS produce neurons as well as astroglia. A characteristic feature of this process, common across all vertebrate species, is that neurogenesis precedes gliogenesis (5) . The molecular mechanisms that control this switch in cell fate are not very well understood. However, the Notch signaling pathway is known to play a fundamental role in this process. During the early neurogenic period, the Notch signaling pathway maintains telencephalic progenitors in an undifferentiated state (6) . At later stages, however, Notch signaling has a distinct and instructive role in astrogliogenesis (7) . In the developing cerebral cortex and spinal cord, Notch signaling activates the transcription factor Nfia, which is necessary and sufficient for astrocytic cell fate (8) (9) (10) (11) . Although Notch signaling is active from early stages in the telencephalic ventricular zone, astrocytes are not generated during the neurogenic phase. The molecular players that prevent astrocyte specification during the neurogenic period remain unknown.
In this study, we report a unique role for Lhx2 in the hippocampus during the phase of active neurogenesis. We show that loss of Lhx2 produces astrocytes prematurely from progenitors that would otherwise produce neurons. On the other hand, overexpression of Lhx2 enhances and prolongs neurogenesis to generate neurons from progenitors that would otherwise give rise to astrocytes. In the hippocampus, astrogliogenesis can also be prematurely induced by overexpressing constitutively active Notch or its target Nfia. Simultaneous overexpression of fulllength Lhx2 can override both of these effects and restore neurogenesis. Lhx2 is able to repress activation of the GFAP promoter, one of the targets of Nfia. Lhx2 therefore acts as a brake on the Notch-Nfia pathway, preventing premature gliogenesis until neurogenesis is complete. Surprisingly, this role of Lhx2 appears to be specific to the hippocampus. In the neocortex, neurons destined for different cortical layers appear to be normally produced despite loss of Lhx2 function in the neocortical progenitors. Our study not only identifies Lhx2 as a key regulator of the neuron-astrocyte cell fate switch in the developing hippocampus but reveals an unexpected spatial selectivity within the telencephalon for this critical function.
Results

Disrupting Lhx2 Function Causes Premature Astrogliogenesis During
the Neurogenic Period of Hippocampal Development. We selectively disrupted the Lhx2 gene using in utero electroporation to introduce Cre recombinase into embryos carrying floxed Lhx2 [Lhx2 conditional knockout (Lhx2 cKO)] (3). Electroporation permits examination of targeted cells in a background of normal cells, which is essential to test for cell-autonomous effects. Electroporation also offers the advantage of control of the timing of gene disruption. We selected E14.5 to E15.5, the peak stage of hippocampal neurogenesis, for electroporation (henceforth called E15) and examined the electroporated embryos 6-8 d after electroporation, during early postnatal stages. This is schematized in Fig. 1A , and a typical hippocampal section is shown in Fig. 1B .
A bicistronic construct encoding Cre recombinase and an EGFP reporter under the CAG promoter was electroporated into Lhx2 cKO embryos. Littermate embryos carrying a WT allele served as controls. At this stage, the hippocampal ventricular zone is known to produce mainly neurons (12) . When examined 7 d later, the majority of GFP-expressing cells in control embryos were found to have assembled into a well-defined pyramidal cell layer, extending arbors characteristic of hippocampal pyramidal neurons and negative for GFAP immunohistochemistry (Fig.  1C) . In contrast, Cre-GFP electroporation into Lhx2 cKO embryos resulted in scattered GFP-expressing cells in and around the pyramidal cell layer that coexpressed GFAP. (Fig. 1D) . A total of 86% of the GFP-expressing cells in Lhx2 cKO brains expressed GFAP compared with 26% in control brains (Fig. 1E) . By postnatal stages, the radial glia in the Ammon's horn (CA fields) are greatly reduced; thus, GFAP labeling, together with the position and distinctive morphology of the electroporated cells, is indicative of an astrocytic cell fate (13) . Therefore, Lhx2 loss of function appears to promote astrogliogenesis from progenitors that would otherwise have produced hippocampal pyramidal neurons (schematized in Fig. 1F ).
Dominant-Negative Construct Recapitulates the Lhx2 Loss-of-Function
Phenotype. All known functions of LIM-HD proteins that have been investigated at the molecular level require Clim cofactors. Two LIM-HD molecules are bridged by a dimer of Clim proteins to produce the transcriptionally active complex (14) (Fig. 2B) . A truncated Clim construct lacking the dimerization domain of Clim (ClimΔDD) inhibits the functional activity of LIM-HD proteins, including Lhx2 (15, 16) (Fig. 2B) . In a pull-down assay, 35 S-labeled ClimΔDD binds the LIM domains of Lhx2 protein (Fig. S1 ). Lhx2 is the only LIM-HD that is expressed in the entire E15.5 hippocampal ventricular zone. Lhx9 has a very limited and weak expression (Fig. S1) , and Lhx5 expression is restricted to Cajal-Retzius cells at this stage (17) .
We used this construct (ClimΔDD-IRES-EGFP) to perturb Lhx2 function in WT mice. This permitted us to explore the mechanism of Lhx2 function in vivo and in vitro further without being constrained by the availability of Lhx2 cKO embryos and also allowed us to examine the role of Lhx2 in other mutant strains. WT brains electroporated with the control GFP construct in utero between E14.5 and E15.5 displayed many GFP-labeled cells in a well-ordered arrangement within the pyramidal cell layer 6-8 d after electroporation. These cells showed characteristic hippocampal pyramidal neuronal morphologies and did not express GFAP (Fig. 2A) . A total of 35% of the GFP-expressing cells were GFAP-positive. In contrast, WT brains electroporated with ClimΔDD displayed electroporated cells scattered in a disorganized manner within and outside the pyramidal cell layer, with irregular morphologies. In these brains, 80% of the GFPexpressing cells were GFAP-positive (Fig. 2D) . Furthermore, these cells coexpressed Aldolase C (AldoC), a marker of astrocytes, but did not express oligodendrocyte marker Olig2 (18) (19) (20) (21) (Fig. 2E) . In summary, ClimΔDD electroporation promotes astrogliogenesis in progenitors that would otherwise produce neurons. This phenotype was seen in both CA1 and CA3 fields and across all rostrocaudal levels of the hippocampus, similar to the phenotype seen when Cre is electroporated into Lhx2 cKO brains (Fig. S2) . To test whether the astrogliogenic effect we observed may have arisen from effects on cell proliferation or cell death instead of cell fate, we examined control GFP and ClimΔDD electroporated brains 1 d after electroporation. Electroporated cells were still at or near the ventricular zone, and some of them coexpressed proliferation marker Ki67. The proportion of GFP cells that were Ki67-positive was similar in control and ClimΔDD brains. Furthermore, staining for activated caspase 3 showed no enhanced cell death in the experimental brains (Fig. S3) . Therefore, interfering with Lhx2 function appears to regulate cell fate per se, apparently without additional effects on progenitor cell proliferation or death.
Overexpression of Lhx2 Enhances and Prolongs Neurogenesis. We tested whether increasing Lhx2 levels in hippocampal progenitors also regulates cell fate. We overexpressed a construct encoding full-length Lhx2 at E15 and analyzed the brains postnatally. Compared with control brains (Fig. 3 A and B) , more cells in Lhx2-overexpressing brains were seen to inhabit the pyramidal cell layer, displaying morphologies appropriate for pyramidal neurons. These cells did not coexpress GFAP (Fig. 3 C  and D) . In contrast to the Lhx2 loss of function that dramatically increased astrogliogenesis, overexpression of Lhx2 at E15 caused a significant decrease in the level of astrogliogenesis (35% decreasing to 10%, Fig. 3I ). Together, these results suggest that Lhx2 promotes neurogenesis by suppressing astrogliogenesis. This raised the possibility that Lhx2 might actively inhibit astrogliogenesis by suppressing gliogenic pathways. To test this idea, we overexpressed Lhx2 at E17, a predominantly gliogenic stage, during which progliogenic pathways are expected to be active. Indeed, control GFP electroporation reveals baseline astrogliogenesis at this stage to be 79%, with electroporated cells showing morphologies and positions appropriate for astrocytes ( Fig. 3 E, F, and I). Lhx2 overexpression suppresses gliogenesis and rescues neurogenesis, such that electroporated cells now display pyramidal neuronal morphologies, occupying the pyramidal cell layer in a neat band, and do not express GFAP ( Fig. 3 G and H) . Thus, Lhx2 overexpression is able to prolong neurogenesis well into the astrogliogenic period, bringing the level of gliogenesis to 31%, similar to the baseline level at E15 (Fig. 3I ).
Lhx2 Can Override the Astrogliogenic Effects of Constitutive Notch
Activation in Vivo. Notch signaling instructs astrogliogenesis in the embryonic telencephalon (7, 22) . Consistent with these studies, we found that constitutive activation of Notch is also a potent inducer of astrogliogenesis in the embryonic hippocampus. We overexpressed a construct that encodes a ligand-independent membrane-associated Notch protein (23) . When cleaved by endogenous γ-secretase, this protein produces the active Notch intracellular domain fragment (NICD). As expected, coelectroporation of this construct at E15 together with a control GFP construct induced robust astrogliogenesis. When scored 6-8 d after electroporation, GFP-expressing cells took up scattered positions in the hippocampus not limited to the pyramidal cell layer, consistent with the normal localization of astrocytes in the hippocampus (Fig. 4 A-C) . A total of 69% of the GFPexpressing cells coexpressed GFAP. In contrast, when the same NICD construct was coelectroporated with a construct encoding full-length Lhx2-GFP, neurogenesis was partially rescued. Several GFP-expressing cells were now positioned within the pyramidal cell layer, displaying distinctive pyramidal neuronal morphologies and β-tubulin expression (Fig. 4 D-F) . With Lhx2-GFP coelectroporation, the proportion of GFAP-expressing electroporated cells decreased to 51% (Fig. 4G ). In summary, Lhx2 coelectroporation was able to override Notch-induced astrogliogenesis in a fraction of NICD-expressing cells. This suggested a model in which Lhx2 regulates astrogliogenesis downstream of Notch activation (Fig. 4H ).
Functional Nfia Is Necessary for Astrogliogenesis Arising from Lhx2
Deprivation. An important target of Notch signaling is the transcription factor Nfia, which is necessary and sufficient for astrogliogenesis (8) (9) (10) (11) . We sought to test whether Lhx2 loss of function can induce astrogliogenesis in the absence of Nfia. However, Nfia mutants die at birth, precluding any such analysis at postnatal stages. Therefore, we set up a combination of ex utero electroporation, followed by an in vitro organotypic explant culture assay. In ex utero electroporation, the brain is dissected out but kept intact and DNA is injected into the ventricle similar to in utero electroporation. Electrodes are applied to the brain as illustrated in the schematic (Fig. 5A ). This ensures that only cells in the ventricular zone incorporate the DNA, similar to in utero electroporation. The brain is then sectioned coronally, and the hippocampal portion is isolated and maintained as an organotypic slice culture. Hippocampal slice cultures have been used extensively in the literature to examine different aspects of hippocampal development and function (24, 25) .
When a control EGFP construct was electroporated, explants displayed axons after 6 d in vitro (Fig. 5B) . These axons were seen to extend toward the fimbria and encircle the periphery of the explant. This trajectory closely parallels the anatomy of hippocampal projections, which grow parallel to the ventricular surface (corresponding to the periphery of the explant) and exit the hippocampus via the fimbria in vivo. In the explant, axons cannot "exit," and are therefore spread out in the region of the fimbria or encircle the explant. Because the extent of electroporation varies from brain to brain, the numbers of axons per explant could not be scored; however, 100% of the control GFP explants, regardless of extent of electroporation, reliably produced robust fiber bundles (Fig. 5 C and K) . In contrast, electroporation of ClimΔDD resulted in a highly penetrant phenotype, such that none of the explants showed the presence of axons (Fig. 5 D and  K) . This phenotype is consistent with the switch to an astrocytic fate observed in vivo and, together with the in utero electroporation data, provides an excellent system to assess the neuron vs. glial fate choice. It also provides an assay to explore the possible interactions of Lhx2 with the gliogenic transcription factor Nfia. (I) GFP-and GFAP-expressing cells were scored in electroporated brains. For E15 electroporations, the proportion of GFP cells that were also GFAP-positive in control GFP embryos was 35%, and in Lhx2-overexpressing embryos, the proportion was 10%. In control E17 embryos electroporated with GFP, the proportion was 79%, and in Lhx2-overexpressing embryos, the proportion was 31%. The bars represent the mean ± SD (**P < 0.0001). (J) Diagram illustrating that Lhx2 overexpression enhances neurogenesis. All high-magnification images are generated from montages of confocal images of GFP (green) and GFAP (red). (Scale bars: low-magnification images, 100 μm; high-magnification images, 20 μm.) A-H are composites assembled from multiple confocal images.
The explant culture assay reliably recapitulated the in vivo results obtained by overexpressing NICD. Whereas NICD + GFP electroporation resulted in a strong phenotype, similar to that seen with ClimΔDD ( Fig. 5 F and K) , coelectroporation of Lhx2-GFP rescued neurogenesis and resulted in explants with axons that resembled the controls (Fig. 5 E and K) . Next, we used embryos from Nfia +/− matings, which gave us both Nfia mutant embryos as well as littermate controls. The control embryos, as expected, always gave explants with axons when electroporated with GFP (100%, Fig. 5 G and K) . When electroporated with ClimΔDD, only 11% of the explants had detectable axons (Fig. 5  H and K) . Nfia mutant explants, when electroporated with GFP, all gave explants with axons (100%), which is expected because Nfia is not known to be required for neurogenesis (Fig. 5 I and  K) . Strikingly, when Nfia mutant explants were electroporated with ClimΔDD, we observed axons in 100% of the explants (Fig.  5 J and K) . This shows that ClimΔDD cannot produce astrocytes unless Nfia is functional and reveals an interaction between Lhx2 and Nfia in regulating astrogliogenesis.
This finding is also supported by experiments in which we used the γ-secretase inhibitor N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester (DAPT) in experiments involving NICD or ClimΔDD (Fig. S4) . Electroporated explants were incubated in 1 μM DAPT on only the first day of the 6-d culture period, after which the DAPT medium was washed out and replaced with normal medium. This limited dose and duration were sufficient to prevent activation and cleavage of the membrane-bound NICD construct, resulting in explants with robust axonal growth (Fig. S4 ) that resembled control GFP electroporated cultures exposed to the same DAPT treatment. Like the NICD explants, ClimΔDD electroporated explants treated with DAPT also appeared unable to induce astrogliogenesis, and instead produced axonal growth (Fig. S4) .
Together, these experiments indicate that astrogliogenesis produced by ClimΔDD electroporation is dependent on an active Notch-Nfia pathway and cannot not occur in Nfia mutant explants or explants treated with the Notch inhibitor DAPT. The role of Lhx2 therefore appears to be to interact with and inhibit this signaling pathway during the neurogenic period.
Lhx2 Can Suppress Nfia-Induced Astrogliogenesis. We further tested the Lhx2-Nfia interaction by electroporating vectors expressing full-length Nfia alone or together with full-length Lhx2. In the control GFP electroporation, 35% of the GFP cells were astrocytes (Fig. 3 A, B, and I) . When Nfia-GFP is overexpressed, 63% of the electroporated cells were astrocytes (Fig. 6 A and I) . Coelectroporation of Lhx2-red fluorescent protein (RFP) together with Nfia-GFP is able to rescue neurogenesis, such that only 13% of the electroporated cells were astrocytes (Fig. 6 B and I) . Significantly, the cells expressing Lhx2-RFP are seen to take positions within the pyramidal cell layer and display neuronal morphologies, even though they express Nfia-GFP (Fig. 6 C and H) . Because Lhx2 appears to be able to suppress Nfia-induced astrogliogenesis robustly, we tested whether Lhx2 regulates GFAP, one of the major targets of Nfia (26) . We used a 2.1 kb fragment of the GFAP promoter that has been previously reported in studies involving Nfia (27) . This region of the GFAP promoter has three Nfia binding sites (11) . A luciferase assay using this promoter showed that Nfia activates the promoter above the baseline level. Lhx2 is able to suppress baseline activation as well as Nfia-induced activation of the GFAP promoter (Fig. 6J ). This reveals a previously undescribed role for Lhx2 as a transcriptional repressor.
The role of Lhx2 therefore appears to be that of a brake on astrogliogenic pathways in the hippocampus during the neurogenic phase of development so as to ensure the production of sufficient numbers of neurons. If this is the case, how are astrocytes produced at all? The finding that ClimΔDD electroporated cells do not become astrocytes in Nfia −/− explants indicates that Lhx2 and Nfia are likely to act in the same cells to regulate this cell fate decision. We examined Lhx2, Notch1, and Nfia expression at a range of developmental stages, from predominantly neurogenic (E12) to predominantly gliogenic [postnatal day (P) 0]. Notch1 is intensely expressed in hippocampal ventricular zone progenitors at E12 and E15. Nfia mRNA expression seems to be relatively weak in the hippocampal ventricular zone at all stages examined (Fig. S5 ), but the protein is known to be robustly expressed in hippopcampal progenitors from E14 to E18 (11) . In contrast, Lhx2 expression displays a dynamic regulation. It is intensely expressed in the hippo- campal primordium at E12 and E15 but appears to decline by P0 (Fig. S5) . Thus, in vivo, Lhx2 levels may drop sufficiently by late embryogenesis to permit Nfia-mediated astrogliogenesis to take off. Indeed, when Lhx2 levels were increased by overexpression at E17, the normally high level of astrogliogenesis was suppressed to a level normally seen at E15 (79-31%, Fig. 3 ).
Lhx2 Loss of Function Does Not Cause Premature Astrogliogenesis in
the Neocortex. Because Lhx2 is expressed in the lateral telencephalic ventricular zone up to E15 (4) (Fig. S5) , we examined whether it also suppresses astrogliogenesis in neocortical progenitors. Surprisingly, neither Cre electroporation in the Lhx2 cKO embryos nor ClimΔDD electroporation in WT E15 embryos appeared to affect the production of neocortical neurons. In each case, electroporated cells migrated to appropriate positions in the superficial layers of the neocortex (Fig. 7 A-C) . These cells displayed the expected morphology of cortical pyramidal neurons and extended axons, and they coexpressed the neuronal marker β-tubulin but did not express GFAP (Fig. 7 B-E) . In contrast to the results in the hippocampus, no increase in astrogliogenesis was seen in the neocortex of ClimΔDD electroporated brains (Fig. 7F) . We also examined this question at an earlier stage, E13, when deep-layer neurons are normally produced. Four days after electroporation, ClimΔDD cells had migrated to the cortical plate and extended apical dendrites as well as axons that coursed through the intermediate zone, similar to control GFP electroporated cells (Fig. S6) . Therefore, Lhx2 does not suppress astrogliogenesis in the neocortex, revealing a surprising spatial restriction for this role.
Discussion
Our study reveals a critical role for Lhx2 in regulating neuronal vs. astrocytic cell fate in the hippocampus. This is a previously undescribed role for the LIM-HD family and extends the established role for members of this group in regulating cell fate across several systems. Apterous, the Drosophila ortholog of Lhx2, functions as a dorsal selector gene in the wing and also regulates neurotransmitter identity in the ventral nerve cord (28, 29) . Similarly, other members of the LIM-HD family determine motor neuron vs. interneuron fate in the vertebrate spinal cord and also instruct particular motor neuron subtype identities (30).
Our study reports LIM-HD gene function in the fundamental step of regulating neuronal vs. nonneuronal cell fate.
Lhx2 Is Necessary and Sufficient for Suppressing Hippocampal
Astrogliogenesis. In the hippocampus, E12 to E16 is the predominantly neurogenic phase, after which gliogenesis peaks. However, gliogenic pathways in this system have not been well studied. Notch and Nfia, two well-studied instructive molecules for neocortical gliogenesis, are expressed in hippocampal progenitors right from the beginning of the neurogenic phase (31) (Fig. S5 ). Lhx2 plays a critical role in hippocampal progenitors by interacting with these known progliogenic regulators, serving as a necessary and sufficient cell intrinsic repressor of gliogenesis.
Lhx2-Notch Pathway Interaction Regulates the Timing of the Neuron-
Glia Cell Fate Switch. In the Drosophila wing, Apterous extensively interacts with the Notch pathway (32). Our results reveal an elegant functional interaction between these two cell fate regulators, such that cell fate in the developing hippocampus appears to depend on the balance between these two pathways. Our data indicate that Lhx2 acts as a brake on astrogliogenesis. Endoge- (Fig. 3) . This number decreased to 10% with Lhx2 overexpression (Fig. 3 ) and increased to 63% in brains overexpressing Nfia-GFP. In Nfia-GFP + Lhx2-RFP coelectroporated brains, astrogliogenesis decreased to 13%. The bars represent the mean ± SD (**P < 0.001). nous Lhx2 expression in hippocampal progenitors is intense during the neurogenic phase and declines when gliogenesis peaks. Down-regulation of Lhx2 in the progenitors in the neurogenic phase causes premature astrogliogenesis. Either constitutive Notch activation or Nfia overexpression during the neurogenic phase also tips the balance toward astrogliogenesis, but simultaneous overexpression of Lhx2 is able to rescue neurogenesis. Overexpression of Lhx2 in the gliogenic phase prolongs neurogenesis. This suggests a model in which high levels of Lhx2 act to repress Notch/Nfia-mediated astrogliogenesis until neurogenesis is complete. A decline in Lhx2 levels may then release the brake on astrogliogenesis, which then becomes the predominant differentiation program from late embryonic stages onward. Thus, Lhx2 level in the progenitor may control the correct timing of the neuron-glia cell fate switch. Notch activation promotes astrogliogenesis via Nfia (9-11) and also via other target genes, such as Hes1, Hes5, Hesr1, and Hesr2 (33) (34) (35) . Notch signaling also interacts with the JAK-STAT pathway to promote astrogliogenesis (7, 36) . This may explain why coelectroporation of Lhx2 suppresses Notch-induced astrogliogenesis only partially (69% decreasing to 51%) but appears to achieve a dramatic suppression of Nfia-induced astrogliogenesis (63% decreasing to 13%). This indicates a highly specific point of interaction of Lhx2 with the Notch pathway in suppressing the astrogliogenic effects of the Notch target Nfia. Removing Lhx2 does not produce astrocytes unless Nfia is functional. This indicates that astrocytes produced as a result of loss of Lhx2 are generated by the Notch-Nfia pathway rather than an independent pathway. Lhx2 therefore interacts with this pathway to suppress its astrogliogenic function.
Lhx2 Has Temporally Distinct Roles. Before E10.5 in the dorsal telencephalon, Lhx2 acts as a cortical selector, where it is required for specifying cortical (hippocampus + neocortex) identity and repressing noncortical (hem/antihem) fates (3) . At later stages, in hippocampal progenitors, Lhx2 controls the fundamental neuron-astrocyte cell fate decision, such that it promotes neurogenesis by suppressing astrogliogenesis.
Notch signaling is also known to have multiple roles in the telencephalic neuroepithelium, an early role in maintaining proliferation of the progenitor pool (37) , and a later role in instructing astrogliogenesis (22, 7) .
Interestingly, Notch and Lhx2 appear to have parallel early roles in maintaining the proliferation and cortical identity of neuroepithelial progenitors, respectively. In contrast, they play opposing roles in regulating the cell fate of the postmitotic progeny arising from these progenitors, such that Notch is progliogenic and Lhx2 suppresses gliogenesis. How the balance between these opposing players is controlled to generate the choreography of neurogenesis followed by astrogliogenesis remains a compelling open question.
Context-Specific Control of Cell Fate. Well-characterized cell fate specification regulators, such as the PDGF, BDNF, Notch, and JAK-STAT pathways or the cell fate determining transcription factor Ngn2, have not been reported to have spatially regulated actions in the developing telencephalon. What mechanisms might underlie the striking disparity in Lhx2 dependence we observe between hippocampal and neocortical progenitors? One unique feature of the medial telencephalon is that it experiences high levels of Wnt signaling, which is an important determinant of neuronal fate in progenitors (38) . Several Wnt genes and their receptors are expressed in the medial telencephalic wall (39, 40) . Lef1, the downstream effector of canonical Wnt signaling, is also expressed at high levels medially and tapers off laterally (41) . A strong medial source of multiple Wnt family members, the cortical hem (39) , is itself regulated by Lhx2, which limits the extent of the hem by repressing hem fate (3) . The combination of high levels of Wnt signaling and high levels of Lhx2 in the medial telencephalon may initiate a program of cell fate regulation whose effect is unique to this region. Thus, Lhx2 itself might be a key participant in the fundamental mechanism that determines the regional specificity of cell fate control mechanisms. Diversity within the broad category of astrocytes is beginning to be appreciated (42) , and it is possible that the regional disparity we report in the regulation of astrocyte production also confers a unique identity to hippocampal astrocytes.
Materials and Methods
DNA Constructs. EGFP, Cre-GFP, Lhx2-GFP, Lhx2-RFP, Nfia-GFP, NICD expression plasmids, and the GFAP promoter-luciferase plasmid are detailed in SI Materials and Methods.
In Utero Electroporation. All procedures followed the Institutional Animal Ethics Committee guidelines. The Lhx2 cKO mice used in this study have been described previously (3).
Immunostaining. The sources, concentrations, and protocols for the antibodies used in this study [rabbit anti-GFP, biotinylated goat anti-GFP, chicken anti-GFP, rabbit anti-GFAP, mouse monoclonal anti-β(III) tubulin isoform, goat anti-Aldo C, rabbit anti-Ki67, rabbit anti-ACTIVE caspase-3, and rabbit anti-Olig2] are detailed in SI Materials and Methods.
Imaging. The different epifluorescence, Apotome (Zeiss), and confocal microscopes used are described in SI Materials and Methods, together with image analysis procedures used.
In Situ Hybridization. In situ hybridization was performed as described by Bulchand et al. (4) . GFAP Promoter Luciferase Assay. U87mg cells (kind gift from Neelam Shirsat, The Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai 410210, India) were used in a standard luciferase assay. The detailed protocol is described in SI Materials and Methods.
Statistical Analysis. Statistical analysis was done using the unpaired t test and GraphPad In-Stat and SigmaPlot Software. The results are expressed as the mean ± SD. For each control and experimental condition, 100 or more cells were counted from sections taken from three to four different electroporated embryos.
Ex Utero Electroporation and Explant Culture. This protocol is described in SI Materials and Methods.
Imaging. Images were taken using a Zeiss Axioplan 2 plus microscope, Zeiss AxioCam camera, and Zeiss Axiovision software for epifluorescence images. For marker colocalization, individual cells in the sections were imaged at a magnification of 63× using the Zeiss Apotome scanning system (Fig. 2 A and C) , Leica SP5 upright confocal (Fig. 2E ) system, and Zeiss LSM 510 (Figs. 2-4 , 6, and 7) and at a magnification of 60× using the Olympus Fluoview Confocal Imaging system (Figs. 1 and 4) . Image stacks were generated by scanning at intervals of 0.5-1.0 μm using filters of the appropriate wavelengths. The stacks were analyzed, merged, and projected using ImageJ software from the National Institutes of Health. Figure panels were prepared using Adobe Photoshop.
GFAP Promoter Luciferase Assay. U87mg cells (kind gift from Neelam Shirsat, The Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai 410210, India) were cultured in DMEM supplemented with 10% (vol/vol) FBS, penicillin (100 U/mL), and streptomycin (100 μg/mL). For transfections, 7 × 10 4 cells per well were seeded into 24-well plates. After an overnight incubation, the medium was removed and 2.1 kb of GFAP-promoter plasmid was added together with GFP (control), Nfia-GFP, Lhx2-RFP, or Nfia-GFP + Lhx2-RFP. Transfection was performed using 2 μL of Lipofectamine-LTX (Invitrogen) in 0.5 mL of medium and incubated for 16 h. Next, the medium-DNA mix was removed and substituted with fresh medium. Renilla luciferase (1 ng) was added to each transfection as a normalization control. Luciferase activity was measured using a commercial dual-luciferase assay system (Promega) 48 h after transfection. All the values are expressed as the mean ± SD of at least three independent experiments carried out in triplicate.
Ex Utero Electroporation and Explant Culture. The embryos were dissected out from the uterus, and the brains were removed and placed in sterile cold L-15 medium. Plasmid DNA (prepared using a Qiagen Maxi-prep kit) was injected into the ventricle of the brain. The brain was then electroporated on the medial side five times with a square-pulse of 50 V for 50 ms, with a 1-s gap between each pulse, using a BTX Electro Square Porator ECM 830 electroporator. Following this, the electroporated hemisphere was separated and the meninges were removed. The hemisphere was then sectioned at 250 μm using a McIllwain tissue chopper. The hippocampal slices were then cultured on a filter in DMEM containing B-27 supplement for 6 d in a 5% CO 2 atmosphere (14) . The medium was changed on the third day. For the DAPT treatment, 1 μM DAPT was added to the medium for the first day. On the second day, the medium was changed three times to wash out residual DAPT and the explants were maintained in fresh medium.
In Vitro Protein-Protein Interaction. 35 S-labeled ClimΔDD (mouse) was expressed in vitro from the DN-CLIM-pCS2-MT plasmid (15) . The Lhx2-LIM bacterial expression plasmid used was pGEX-Lhx2-LIM (14) . GST pull-down experiments were performed as described by Bach et al. (1) . . ClimΔDD does not result in aberrant proliferation or cell death. E15 control GFP and ClimΔDD electroporated brains were examined 1 d after electroporation. dpe, days postelectroporation. Electroporated cells (green) were still at or near the ventricular zone, and similar proportions of these coexpressed proliferation marker Ki67 (red) in control (51.7%) and ClimΔDD (58.4%) electroporated brains (not significant; P > 0.05). The sections were counterstained with DAPI (blue). Similarly, staining for activated caspase 3 (red, arrowheads) did not show any enhanced cell death in the experimental brains. A few positive cells were detected in the adjacent portion of the thalamus of both control and ClimΔDD electroporated brains, providing an internal control for the activated caspase staining. S5 . Lhx2, Notch1, and Nfia expression across development. In situ hybridization in sections of E12, E15, and P0 brains display intense Lhx2 expression intensely in the hippocampal ventricular zone at E12 and E15. This expression declines by P0. Nfia expression appears weakly detectable in the hippocampal ventricular zone at all these ages. Notch1 is intensely expressed in the E12 and E15 brains in the hippocampal ventricular zone. 
